Anna U. Loengard - 06 Jan 2025 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role
Director
Signature
/s/Peter J. Rivas as attorney-in-fact for Anna U. Loengard
Issuer symbol
CLOV
Transactions as of
06 Jan 2025
Net transactions value
$0
Form type
4
Filing time
08 Jan 2025, 16:39:51 UTC
Previous filing
20 May 2024
Next filing
14 Aug 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLOV Class A Common Stock Award $0 +60,975 +11% $0.000000 599,816 06 Jan 2025 Direct F1, F2
holding CLOV Class A Common Stock 15,600 06 Jan 2025 By Son IRA
holding CLOV Class A Common Stock 15,110 06 Jan 2025 By Daughter IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2025, subject to the Reporting Person's continued service as a director through such vesting date.
F2 The Reporting Person no longer has a reportable indirect beneficial interest in the following shares: (i) 20,000 shares of the Issuer's Class A Common Stock previously acquired by the Reporting Person and held by her now ex-spouse's IRA; and (ii) 1300 and 1500 shares of the Issuer's Class A Common Stock held by her Son's and Daughter's custodial accounts, respectively, and previously acquired by the Reporting Person. Each such holding was included in the Reporting Person's prior ownership report.